Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Obesity: a perfect storm for carcinogenesis.
Harris BHL, Macaulay VM, Harris DA, Klenerman P, Karpe F, Lord SR, Harris AL, Buffa FM. Harris BHL, et al. Among authors: macaulay vm. Cancer Metastasis Rev. 2022 Sep;41(3):491-515. doi: 10.1007/s10555-022-10046-2. Epub 2022 Aug 30. Cancer Metastasis Rev. 2022. PMID: 36038791 Free PMC article. Review.
Phase I study of the mitomycin C analogue BMS-181174.
Macaulay VM, O'Byrne KJ, Green JA, Philip PA, McKinley L, LaCreta FP, Winograd B, Ganesan TS, Harris AL, Talbot DC. Macaulay VM, et al. Br J Cancer. 1998 Jun;77(11):2020-7. doi: 10.1038/bjc.1998.336. Br J Cancer. 1998. PMID: 9667686 Free PMC article. Clinical Trial.
A phase II study of bryostatin 1 in metastatic malignant melanoma.
Propper DJ, Macaulay V, O'Byrne KJ, Braybrooke JP, Wilner SM, Ganesan TS, Talbot DC, Harris AL. Propper DJ, et al. Br J Cancer. 1998 Nov;78(10):1337-41. doi: 10.1038/bjc.1998.680. Br J Cancer. 1998. PMID: 9823975 Free PMC article. Clinical Trial.
IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancer.
Aleksic T, Verrill C, Bryant RJ, Han C, Worrall AR, Brureau L, Larré S, Higgins GS, Fazal F, Sabbagh A, Haider S, Buffa FM, Cole D, Macaulay VM. Aleksic T, et al. Among authors: macaulay vm. Br J Cancer. 2017 Nov 21;117(11):1600-1606. doi: 10.1038/bjc.2017.337. Epub 2017 Oct 3. Br J Cancer. 2017. PMID: 28972962 Free PMC article.
A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer.
Macaulay VM, Lord S, Hussain S, Maroto JP, Jones RH, Climent MÁ, Cook N, Lin CC, Wang SS, Bianchini D, Bailey M, Schlieker L, Bogenrieder T, de Bono J. Macaulay VM, et al. Br J Cancer. 2023 Oct;129(6):965-973. doi: 10.1038/s41416-023-02380-1. Epub 2023 Aug 3. Br J Cancer. 2023. PMID: 37537253 Free PMC article. Clinical Trial.
83 results